Why Specialty Pharmacy is Key to Collaborative Care
By AmerisourceBergen
“A multidisciplinary approach to patient care that aligns oncologists and specialty pharmacists — from diagnosis to initial dispense to completion of therapy — is critical to the creation of positive outcomes. By collaborating with providers in areas such as communication, patient education and adverse effect management, specialty pharmacies can help create a clinically-coordinated care model that allows oncology patients to truly benefit from treatment and live longer lives.”
- Kelly Ratliff, President Emeritus, US Bioservices
“Collaboration in the specialty pharmacy space is critical for the patient. The physician is making the treatment decision, but often the manufacturer will provide additional services to support patients. The specialty pharmacy really sits in the middle. We connect those different stakeholders in the patient’s journey to support medication adherence throughout their regimen.”
- Joy Gilbert, Vice President of Operations, US Bioservices
“PBMs, manufacturers and pharmacies are focused on common goals around increasing patient access and improving outcomes. Specialty pharmacies play a key role in getting patients on therapy quickly and working with providers to help them navigate formularies for payers or prior authorization requirements. We also enhance communication between the various stakeholders by providing access to critical information through real-time visibility and transparency into activities within the pharmacy itself.”
- Kevin James, Vice President of Payer Strategy, US Bioservices
“This new era of integration, collaboration and coordination highlights what makes US Bioservices’ model for provider-led specialty pharmacy so unique. While vertical integration happens around us, we’re aligning our services with the sites of care where patients prefer to be treated.”
- Randy Maloziec, Vice President of Business Development, US Bioservices
